Page last updated: 2024-10-18

kynurenine and Myasthenia Gravis

kynurenine has been researched along with Myasthenia Gravis in 1 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamczyk-Sowa, M1
Bieszczad-Bedrejczuk, E1
Galiniak, S1
Rozmiłowska, I1
Czyżewski, D1
Bartosz, G1
Sadowska-Bartosz, I1

Other Studies

1 other study available for kynurenine and Myasthenia Gravis

ArticleYear
Oxidative modifications of blood serum proteins in myasthenia gravis.
    Journal of neuroimmunology, 2017, 04-15, Volume: 305

    Topics: Adult; Advanced Oxidation Protein Products; Aged; Aged, 80 and over; Autoantibodies; Benzothiazoles;

2017